People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Perkinelmer Inc | — | Biotech | Growth/Late | $2.2B | $65.2B | 2021 |
Andrew R. Okun at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew R. Okun on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joel S Goldberg | 1 | 2 |
| Sylvie R. Gregoire | 1 | 1 |
| Michel P. Vounatsos | 1 | 1 |
| Samuel R. Chapin | 1 | 1 |
| James M. Mock | 1 | 1 |
| Pascale P. Witz | 1 | 1 |
| Prahlad Singh | 1 | 1 |
| Alexis P. Michas | 1 | 1 |
| Frank P. Witney | 1 | 1 |
| Tajinder R. Vohra | 1 | 1 |
| Peter R. Barrett | 1 | 1 |
| Miriame R. Victor | 1 | 1 |
| Daniel R. Tereau | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.